Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hormones of the Pituitary Gland01:27

Hormones of the Pituitary Gland

The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-secretion of growth hormone and prolactin defines a high-risk acromegaly phenotype.

Pituitary·2026
Same author

Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy.

Frontiers in endocrinology·2025
Same author

Author Correction: Novel mechanism whereby metformin improves glucose homeostasis: TXNIP-GLUT1 axis modulation enhances intestinal glucotonic effects.

Experimental & molecular medicine·2025
Same author

Novel mechanism whereby metformin improves glucose homeostasis: TXNIP-GLUT1 axis modulation enhances intestinal glucotonic effects.

Experimental & molecular medicine·2025
Same author

Circulating miR-20a-5p as a biomarker associated with cabergoline responsiveness in patients with hyperprolactinemia and pituitary adenomas.

European journal of endocrinology·2025
Same author

Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy.

Frontiers in endocrinology·2025

Related Experiment Video

Updated: Jun 19, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Predicting recurrence of nonfunctioning pituitary adenomas.

Tae-Woong Noh1, Hyeong Jae Jeong, Mi-Kyung Lee

  • 1Pituitary Tumor Clinic and Institute of Endocrinology, Yonsei Brain Research Institute, Yonsei University College of Medicine, 120-752 Seoul, Korea.

The Journal of Clinical Endocrinology and Metabolism
|October 13, 2009
PubMed
Summary

Predicting nonfunctioning pituitary adenoma recurrence is possible using cellular markers. High levels of phospho-Akt and phospho-p44/42 MAPK, along with low phospho-CREB and ZAC1, indicate a higher risk of recurrence.

More Related Videos

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Related Experiment Videos

Last Updated: Jun 19, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Nonfunctioning pituitary adenomas are often large at diagnosis, leading to surgery and potential recurrence.
  • Predicting recurrence post-surgery is crucial for determining the need for adjunctive therapies and reducing patient morbidity.

Purpose of the Study:

  • To identify cellular markers that can predict the recurrence of nonfunctioning pituitary adenomas after initial surgery.
  • To correlate specific cellular marker expression levels with the timing and likelihood of tumor recurrence.

Main Methods:

  • Utilized a tissue array block from 35 nonfunctioning pituitary adenoma cases, categorized by recurrence status (early, late, none).
  • Analyzed cellular markers associated with proliferation and apoptosis using immunohistochemical studies.

Main Results:

  • High Ki-67 and TUNEL labeling indexes correlated with tumor recurrence.
  • Elevated expression of phospho-Akt, phospho-p44/42 MAPK, and PTTG1 was linked to early recurrence.
  • Conversely, high expression of phospho-CREB and ZAC1 showed an inverse association with recurrence.

Conclusions:

  • Tumors exhibiting high phospho-Akt and phospho-p44/42 MAPK expression, and low phospho-CREB and ZAC1 expression, warrant close monitoring.
  • These marker profiles suggest a higher risk of recurrence, potentially necessitating adjunctive therapies.